ursodeoxycholic acid has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, S; Jansen, E; Nikolova, V; Papacleovoulou, G; Pataia, V; Poston, L; Samuelsson, AM; Taylor, PD; Williamson, C | 1 |
| Ivashkin, KV; Ivashkin, VT; Leshchenko, VI; Liusina, EO; Lunkov, VD; Maevskaya, MV; Zozula, VN | 1 |
| Al-Salami, H; Elahy, M; Lam, V; Mamo, JC; Mooranian, A; Negrulj, R; Takechi, R | 1 |
1 review(s) available for ursodeoxycholic acid and Hypertension
| Article | Year |
|---|---|
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy.
Topics: Cholagogues and Choleretics; Humans; Hypertension; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Risk Factors; Ursodeoxycholic Acid | 2019 |
2 other study(ies) available for ursodeoxycholic acid and Hypertension
| Article | Year |
|---|---|
Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment.
Topics: Animals; Body Weight; Cholestasis; Diet, Western; Fathers; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; Obesity; Ursodeoxycholic Acid | 2019 |
Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance.
Topics: Angiotensin II; Animals; Capsules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Hypertension; Insulin Resistance; Male; Mice; Time Factors; Ursodeoxycholic Acid | 2017 |